16.05.2014
- Shortly before expiration of the patent on the multiple sclerosis treatment Copaxone, a US district court has dismissed a case by Teva Pharmaceutical Industries, subsidiary of the...
15.05.2014
- AstraZeneca's chief executive Pascal Soriot said in an interview with the news agency Reuters he would engage with Pfizer if the price was right and the risks posed from forcing...
14.05.2014
- A day after U.S. drugmaker Allergan rejected its initial takeover approach, Canada's Valeant Pharmaceuticals International said it would "improve" the unsolicited $47 billion offer...
13.05.2014
- U.S. drugmaker Allergan has rejected the $47 billion takeover bid of Canada-based Valeant Pharmaceuticals International, saying the suitor's proposed cost cuts of at least $2.7...
12.05.2014
- U.S. drugmaker Pfizer has dismissed criticism that its planned takeover of rival AstraZeneca would damage Britain's science base, saying strong UK research was a key reason for the...
08.05.2014
- British prime minister David Cameron has called on U.S. drugmaker Pfizer to give stronger guarantees it will keep jobs and investment in the UK if it is to secure his government's...
08.05.2014
- A Pharma Veteran's View - Dr. John L. LaMattina is the former Senior Vice President of Pfizer, and President, Pfizer Global Research and Development. In this role, Dr. LaMattina...
08.05.2014
- Changing Roles - China's far-reaching presence in the manufacture and supply of active pharmaceutical ingredients (APIs) around the world has long been known. However, with the...
